angiotensin ii has been researched along with n-(2-(mercaptomethyl)-3-phenylbutanoyl)-l-alanine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FourniƩ-Zaluski, MC; Gonzalez Vera, W; Laboulandine, I; Michel, JB; Pham, I; Roques, BP | 1 |
1 other study(ies) available for angiotensin ii and n-(2-(mercaptomethyl)-3-phenylbutanoyl)-l-alanine
Article | Year |
---|---|
Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Topics: Alanine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Male; Natriuresis; Neprilysin; Rats; Rats, Inbred SHR; Rats, Wistar; Renin | 1995 |